Asianfin -- XuZhiShi Technology, an AI healthcare and neuroscience company based in Hangzhou, has completed its Series A funding round, raising tens of millions of yuan. The round was led by XingTuo Capital, with participation from AIalpha Ventures and other investors. The funds will primarily be used to accelerate the development of both domestic and international medical products, as well as to build teams for the C-end consumer market and expert sectors. Moving forward, the company aims to strengthen its leadership position in the digital treatment of brain diseases in China, while exploring innovative business models to deliver superior products and services to users.